By Skyepharma Production…
To get in touch with Skyepharma Production S.A.S., simply fill out the form below.
Subscribe to Supplier
CDMO Skyepharma preparing for virtual CPhI Festival of Pharma 2020
Saint-Quentin-Fallavier, France: – Skyepharma Productions S.A.S. (Skyepharma), the French-based fully-formed contract development and manufacturing organisation (CDMO), will deliver on its earlier commitment to CPhI Worldwide 2020 by fully participating in the online CPhI ‘Festival of Pharma’ that will replace the Milan expo, scheduled for mid-October.
CPhI organisers Informa Markets had hoped to retain CPhI Worldwide as a physical event at the Fiero Milano center, where the Skyepharma stand at Booth 2D50 in Hall 2 would have exhibited its R&D capabilities, its expertise in oral solid forms and its controlled release technologies.
Festival of Pharma
Informa has now decided that the continuing Covid-19 pandemic makes physical gatherings too problematic, with travel restrictions making it problematic even to visit Milan. It will instead stage the virtual ‘CPhI: Festival of Pharma’ over a longer time span, opening October 5 and running through to October 15.
The online event will use ‘the most advanced digital ecosystem ‘, to bring together the world’s leading pharma companies, expert speakers and extensive networking opportunities.
Skyepharma will still use the virtual event to present to a global audience its expanded capabilities, technologies and supply chain strengths, that have allowed it to maintain on time deliveries despite the coronavirus emergency.
Skyepharma President David Lescuyer commented: “In our previous appearances at CPhI, we would reckon to have around 200 meetings over three days. Our challenge now will be to improve on that over the ten days of the virtual Festival.”
“We will dedicate our whole commercial and technical teams, led by our Business Development & Marketing Director, Laurent Rigaudeau, and Business Development Manager, Florence Lemoult, to this online event,” M. Lescuyer pledged.
“We have a very strong story to communicate to pharma companies of all sizes as well as biotechs and other organisations looking to outsource their production and R&D,” said Mr. Rigaudeau.
“We have now 150 employees, almost twice as many as we did just four years ago and have now become a credible and reliable CDMO in the market for solid oral forms, with sophisticated R&D capabilities that have yielded three technologies: Geomatrix®, Geoclock®, and Soctec® that set world-class standards for controlled release,” Mr. Rigaudeau explained.
Florence Lemoult said Skyepharma would be supporting its CPhI Festival participation with an energetic multi-channel communications campaign.
“As well as using the Festival networking platform, there will be a meeting platform on our own website, supported by communications there and on social media. We will also stage a special webinar to co-incide with the CPhI Festival to communicate on our technologies,” said Ms. Lemoult.
About Skyepharma Production
Skyepharma Production S.A.S. (Skyepharma) is a specialist CDMO with particular expertise and capabilities in oral solid dosage forms, being a key player in drug development and delivery of oral technologies serving the global pharmaceutical, biotech and consumer health industries.
Skyepharma is the oral business unit of the Vectura Group of companies, an international leader in inhalation and other drug delivery forms.
As an integrated CDMO, The company’s vision is to help solve healthcare industry complexity with a mission to provide a dedicated and results-oriented team to deliver advanced oral dosage services to the healthcare industry through state-of-the-art facilities, scientific expertise and open, transparent relationships. All of this is summed up in its strapline: ‘Expert and Agile CDMO partner for tailor-made solutions’.
The Skyepharma CDMO offer in solid oral dosage formats encompasses the whole value chain, including Formulation Development & Process Design, Analytical Development, Scale-up, Manufacturing, Packaging, Serialisation and Aggregation.
Skyepharma also provides a range of support services that help client companies from early stage development (up to phase III), through scale-up and full commercial manufacturing and packaging to market introduction, including controlled substance handling, QbD methodology (FMEA, FTA, DOE), Troubleshooting, regulatory services, validation, registration and warehousing services.
About CPhI Festival of Pharma 2020
CPhI Worldwide is the flagship annual trade show for pharma ingredients and partner sourcing providing delegates and exhibitors’ opportunities to arrange face-to-face meetings with potential international pharmaceutical partners and collaborators and gain insights on latest industry trends.
Now in its 31st year, the 2020 expo was planned as a three-day event opening October 13 at the Fiero Milano expo center in Milan, Italy, to include the co-located zoned exhibitions; ICSE Outsourcing solutions, P-MEC Machinery and Equipment, FDF for finished dosage formulations, InnoPack for pharmaceutical packaging and events and the new BioProduction conference focusing on bioprocessing and manufacturing.
The combined events are expected to attract delegates from some 160 countries, along with more than 2,500 exhibiting companies. However, during June 2020, the CPhI events team from leading global B2B Events organiser and publisher Informa Markets decided that the global scale of the event combined with the social distancing required to combat COVID-19 required the postponement of CPhI Worldwide to autumn 2021.
To replace the Milan event, Informa will stage the 2020 CPhI Festival of Pharma as the world’s largest pharmaceutical virtual meeting, using online technologies to create a networking platform that will combine the world’s leading pharma companies, eminent speakers and extensive networking opportunities.
An advanced digital ecosystem will allow the participation of some 20,000 virtual ‘attendees’ representing from more than 700 pharma companies. The virtual Festival will run between October 5 and 15 and will include an interactive digital marketplace for sourcing of products and services as well as through an enhanced ‘matchmaking’ platform to connecting new and existing partners from the global pharma community, alongside a high-level content program.
Further information at: https://www.cphi.com/europe/en/about/news-and-updates/event-postponed-new-pharma-festival.html
Click on SkyePharma Events to watch videos and see latest events updates.
David Lescuyer (far left) with Skyepharma team at CPhI Frankfurt 2019